MENU
Aim higher

TREAT-MEMT

The development of a novel medicine for advanced prostate cancer

This project will deliver a novel treatment for prostate carcinoma, which is based on a unique and patented compound that is able to reverse Epithelial-Mesenchymal Transition (EMT). EMT is a process associated with cancer invasion, therapy resistance, and the plasticity of cancer- and metastasis-initiating cells. Since EMT is associated with many epithelial cancer types, this drug can be applied to different types of carcinomas including breast, lung, pancreas, skin and bladder cancer.
Acronym: 
TREAT-MEMT
Project ID: 
9 386
Ranking: 
42
Cut-off: 
2
Start date: 
06-07-2015
Project Duration: 
36months
Project costs: 
2 460 420.00€
Technological Area: 
Cytology, Cancerology, Oncology
Market Area: 
Other therapeutic (including defibrillators)